dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
Published 5 years ago • 676 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:58
dr. pishvaian on fda approval of atezolizumab plus bevacizumab in hcc
-
1:27
fda approval of atezolizumab for nsclc
-
1:12
dr. horn discusses next steps with atezolizumab in sclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
1:27
dr. rini on the tolerability of atezolizumab plus bevacizumab in rcc
-
2:38
dr. mittendorf highlights fda approval of atezolizumab/nab-paclitaxel in pd-l1 tnbc
-
1:22
dr. horn on updated data from impower133 in small cell lung cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
7:05
the fda approval of atezolizumab in bladder cancer
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
1:07
dr. horn on the role of mobocertinib in nsclc
-
1:14
dr. mcgregor on the combination of atezolizumab and bevacizumab in rcc